BioCentury
ARTICLE | Clinical News

Lefamulin: Ph III LEAP 1 ongoing

February 3, 2017 5:33 PM UTC

An independent committee recommended continuation of the double-blind, international Phase III LEAP 1 trial comparing IV and oral lefamulin vs. IV and oral moxifloxacin with or without Zyvox linezolid...

BCIQ Company Profiles

Nabriva Therapeutics plc

BCIQ Target Profiles

50S ribosomal subunit